Perrigo | PRGO - Selling And Administration Expenses


Perrigo reported $245.7M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Abbott USD 3.13B 125M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Corcept Therapeutics USD 106.97M 3.12M Sep/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Eli Lilly USD 2.74B 12.3M Sep/2025
J&J USD 6.75B 831M Dec/2025
Merck USD 2.63B 0 Sep/2025
Nestle CHF 12.73B 181M Jun/2025
Pacira USD 91.8M 14.6M Sep/2025
Perrigo USD 245.7M 27.4M Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Prestige Brands USD 28.04M 419K Sep/2025
Sanofi EUR 2.75B 455M Dec/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025
Zoetis USD 579M 29M Sep/2025